Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
J Proteome Res ; 13(7): 3444-54, 2014 Jul 03.
Artículo en Inglés | MEDLINE | ID: mdl-24922590

RESUMEN

Prostate cancer (PCa) is the second leading cause of cancer-related mortality in men. The prevalent diagnosis method is based on the serum prostate-specific antigen (PSA) screening test, which suffers from low specificity, overdiagnosis, and overtreatment. In this work, untargeted metabolomic profiling of age-matched serum samples from prostate cancer patients and healthy individuals was performed using ultraperformance liquid chromatography coupled to high-resolution tandem mass spectrometry (UPLC-MS/MS) and machine learning methods. A metabolite-based in vitro diagnostic multivariate index assay (IVDMIA) was developed to predict the presence of PCa in serum samples with high classification sensitivity, specificity, and accuracy. A panel of 40 metabolic spectral features was found to be differential with 92.1% sensitivity, 94.3% specificity, and 93.0% accuracy. The performance of the IVDMIA was higher than the prevalent PSA test. Within the discriminant panel, 31 metabolites were identified by MS and MS/MS, with 10 further confirmed chromatographically by standards. Numerous discriminant metabolites were mapped in the steroid hormone biosynthesis pathway. The identification of fatty acids, amino acids, lysophospholipids, and bile acids provided further insights into the metabolic alterations associated with the disease. With additional work, the results presented here show great potential toward implementation in clinical settings.


Asunto(s)
Biomarcadores de Tumor/sangre , Neoplasias de la Próstata/diagnóstico , Anciano , Biomarcadores de Tumor/aislamiento & purificación , Estudios de Casos y Controles , Cromatografía Líquida de Alta Presión , Estudios de Factibilidad , Humanos , Masculino , Metabolómica , Persona de Mediana Edad , Neoplasias de la Próstata/sangre , Espectrometría de Masas en Tándem
2.
Sci Rep ; 5: 16351, 2015 Nov 17.
Artículo en Inglés | MEDLINE | ID: mdl-26573008

RESUMEN

High performance mass spectrometry was employed to interrogate the serum metabolome of early-stage ovarian cancer (OC) patients and age-matched control women. The resulting spectral features were used to establish a linear support vector machine (SVM) model of sixteen diagnostic metabolites that are able to identify early-stage OC with 100% accuracy in our patient cohort. The results provide evidence for the importance of lipid and fatty acid metabolism in OC and serve as the foundation of a clinically significant diagnostic test.


Asunto(s)
Biomarcadores de Tumor/sangre , Detección Precoz del Cáncer/normas , Metabolómica , Neoplasias Ováricas/sangre , Neoplasias Ováricas/patología , Adulto , Anciano , Antígeno Ca-125/sangre , Estudios de Casos y Controles , Cromatografía Líquida de Alta Presión , Femenino , Humanos , Lisofosfolípidos/sangre , Metaboloma , Persona de Mediana Edad , Neoplasias Ováricas/metabolismo , Análisis de Componente Principal , Sensibilidad y Especificidad , Máquina de Vectores de Soporte , Espectrometría de Masas en Tándem
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA